# GlucoShield — Phase 7C Final Completion & Verification Report
**Document ID:** `GLUCOSHIELD-RPT-PHASE7C-COMPLETE-001`  
**Certified Protocol Version:** `v2.1.0`  
**Timestamp:** 2026-08-28T19:47:00 Local Time  
**Author:** Lead Deep Learning & Physiological Systems Engineer  
**Status:** **PHASE 7C BENCHMARK COMPLETE, FROZEN, AND REPRODUCIBLE**  

---

## 1. Executive Summary & Authoritative Scientific Conclusion

Phase 7C (Multimodal Wearable Activity Ablation Benchmark) has completed under locked Protocol Version 2.1.0 with complete statistical governance, 13-fold Leave-One-Patient-Out Cross-Validation (LOOCV), and zero leakage.

### Authoritative Scientific Finding:
> **“In this pre-registered 13-participant endogenous/free-living Glucdict benchmark, the tested wearable activity feature set did not demonstrate a statistically significant out-of-fold improvement over the CGM-based baseline.”**

---

## 2. Independent Metric Recomputation & Verification

* **Cross-Validation Scheme:** 13 Folds, each with **11 Train, 1 Val, 1 Test** participant.
* **Total Participants Tested:** **13 / 13 Unique Participants** (every participant tested out-of-sample exactly once).
* **Baseline Model A (22 Dynamic Channels):** Out-of-fold Mean $\text{MAE} = \mathbf{12.72\text{ mg/dL}}$
* **Multimodal Model B (28 Multimodal Channels):** Out-of-fold Mean $\text{MAE} = \mathbf{12.93\text{ mg/dL}}$
* **Overall $\Delta\text{MAE} (\text{Model A} - \text{Model B})$:** $\mathbf{-0.21\text{ mg/dL}}$ ($\mathbf{-1.64\%}$)
* **Active & Recovery Horizon $\Delta\text{MAE}$:** $\mathbf{-0.23\text{ mg/dL}}$
* **Paired Two-Sided Wilcoxon Signed-Rank Test ($N = 13$):** $\mathbf{W = 34.0, \; p = 0.454834}$ ($p \ge 0.05$, **NOT STATISTICALLY SIGNIFICANT**)
* **Consistency Check:** Recomputed Python statistics match `phase7c_ablation_results.json` and `phase7c_ablation_results.csv` bit-for-bit.

---

## 3. Participant-Level Out-of-Fold Error Summary ($N = 13$)

| Fold | Held-Out Test Subject | Model A MAE ($\text{mg/dL}$) | Model B MAE ($\text{mg/dL}$) | $\Delta\text{MAE} (\text{A} - \text{B})$ | Percent Change | Active Horizon $\Delta\text{MAE}$ |
|:---:|:---:|:---:|:---:|:---:|:---:|:---:|
| **00** | **User8** | $14.98$ | $15.14$ | $-0.16\text{ mg/dL}$ | $-1.06\%$ | $-0.26\text{ mg/dL}$ |
| **01** | **User6** | $10.79$ | $10.75$ | $+0.04\text{ mg/dL}$ | $+0.38\%$ | $+0.13\text{ mg/dL}$ |
| **02** | **User1** | $14.89$ | $14.42$ | $+0.47\text{ mg/dL}$ | $+3.17\%$ | $-0.05\text{ mg/dL}$ |
| **03** | **User5** | $9.00$ | $9.69$ | $-0.69\text{ mg/dL}$ | $-7.67\%$ | $-0.89\text{ mg/dL}$ |
| **04** | **User15** | $13.39$ | $15.31$ | $-1.92\text{ mg/dL}$ | $-14.30\%$ | $-2.31\text{ mg/dL}$ |
| **05** | **User12** | $9.64$ | $9.54$ | $+0.11\text{ mg/dL}$ | $+1.10\%$ | $+0.10\text{ mg/dL}$ |
| **06** | **User10** | $10.45$ | $10.66$ | $-0.21\text{ mg/dL}$ | $-1.97\%$ | $-0.18\text{ mg/dL}$ |
| **07** | **User9** | $12.56$ | $12.41$ | $+0.15\text{ mg/dL}$ | $+1.16\%$ | $+0.01\text{ mg/dL}$ |
| **08** | **User14** | $29.48$ | $29.01$ | $+0.47\text{ mg/dL}$ | $+1.60\%$ | $+0.28\text{ mg/dL}$ |
| **09** | **User4** | $12.57$ | $13.49$ | $-0.92\text{ mg/dL}$ | $-7.33\%$ | $-0.75\text{ mg/dL}$ |
| **10** | **User7** | $6.22$ | $6.70$ | $-0.48\text{ mg/dL}$ | $-7.77\%$ | $-0.11\text{ mg/dL}$ |
| **11** | **User13** | $10.77$ | $10.47$ | $+0.31\text{ mg/dL}$ | $+2.84\%$ | $+0.85\text{ mg/dL}$ |
| **12** | **User3** | $10.67$ | $10.55$ | $+0.12\text{ mg/dL}$ | $+1.11\%$ | $+0.22\text{ mg/dL}$ |
| **Mean** | — | **$12.72$** | **$12.93$** | **$-0.21\text{ mg/dL}$** | **$-1.64\%$** | **$-0.23\text{ mg/dL}$** |

---

## 4. Immutable Artifact Manifest & Cryptographic Hashes

### Primary Results Artifacts:
* `phase7c_ablation_results.json` — SHA-256: `18f152e008a0d0d8bbd47cb4eef7bfeb6ffbb3c92df636dc99b9cf9c77cbda77`
* `phase7c_ablation_results.csv` — SHA-256: `66d0cbfecb44081c7e143b8c7b8226e6c71c4c11b1fa9f3cefb2ff5502a5cfa7`
* `phase7c_ablation_config.yaml` — SHA-256: `d377b21e8e5033c9453965b706c6a46132f8319e782d27f8045610bc9ea0b3f5`
* `participant_kfold_manifest.json` — SHA-256: `a7d4e5f70bbbe25091a136bfb1b72dc6a9db3fcf224c6d3bc0a6bc948a3aa698`

### Generated Scientific Figures:
* `figures/phase7c_participant_mae_comparison.png`
* `figures/phase7c_participant_delta_mae.png`
* `figures/phase7c_paired_distribution.png`
* `figures/phase7c_overall_mae_comparison.png`
* `figures/phase7c_13fold_evaluation_diagram.png`

### Fold Checkpoints (26 Saved Checkpoints):
* All 26 `.pt` model checkpoints in `activity_telemetry/experiments/checkpoints/` verified intact and cataloged in `phase7c_immutable_artifact_manifest.json`.

---

## 5. GlucoShield V1 Core Preservation Verification

The frozen production core remains bitwise unmodified:
* `models/glucoshield_neural_best.pt` — SHA-256: `026af3341a91064104d5ff88ebc2759e5ce6cbe01a5906d4e59000b21a8d1162` (**INTACT**)
* `models/glucoshield_hybrid_best.pt` — SHA-256: `89a67710aa493124ae87aa09df63aa876615b3c4ba7802cbaf888d3dca40ffc2` (**INTACT**)
* Dataset v1.0, ODE Digital Twin, Decision Engine, and Phase 6 benchmarks — **PERFECTLY PRESERVED**.

---
*Certified under Phase 7C Finalization & Reproducibility Protocol.*
